{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:38:05Z","timestamp":1794591485306,"version":"4.9.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.mayocp.2019.11.005","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T17:11:36Z","timestamp":1593277896000},"page":"2005-2020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Cerebral Cavernous Malformation: What a Practicing Clinician Should Know"],"prefix":"10.1016","volume":"95","author":[{"given":"Kelly D.","family":"Flemming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lanzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib1","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.3171\/foc.2006.21.1.7","article-title":"Are cavernous sinus hemangiomas and cavernous malformations different entities?","volume":"21","author":"Gonzalez","year":"2006","journal-title":"Neurosurg Focus"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib2","first-page":"422","article-title":"The natural history of familial cavernous malformations: results of an ongoing study","volume":"80","author":"Zabramski","year":"1994","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17554\/j.issn.2313-3406.2015.02.15","article-title":"The MRI imaging of cerebral cavernous malformation with practical use of diffusion weighted image","volume":"2","author":"Kazawa","year":"2015","journal-title":"Int J Radiol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib4","first-page":"518","article-title":"The MRI appearance of cavernous malformations (angiomas)","volume":"67","author":"Rigamonti","year":"1987","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib5","first-page":"128","article-title":"131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies","volume":"35","author":"Otten","year":"1989","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.mayocp.2019.11.005_bib6","series-title":"Pathology of the Central Nervous System","author":"Courville","year":"1950"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3171\/2011.11.PEDS11390","article-title":"Natural history and imaging prevalence of cavernous malformations in children and young adults","volume":"9","author":"Al-Holou","year":"2012","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1673.1993.tb00039.x","article-title":"Cavernous haemangiomas (angiomas) of the brain: clinically significant lesions","volume":"37","author":"Sage","year":"1993","journal-title":"Australas Radiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib9","first-page":"702","article-title":"An analysis of the natural history of cavernous angiomas","volume":"75","author":"DelCurling","year":"1991","journal-title":"J\u00a0Neurosurg"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.005_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","article-title":"Population-based prevalence of cerebral cavernous malformations in older adults: Mayo Clinic Study of Aging","volume":"74","author":"Flemming","year":"2017","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(12)70004-2","article-title":"Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study","volume":"11","author":"Al-Shahi Salman","year":"2012","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2019.11.005_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11886-017-0931-1","article-title":"Clinical management of cavernous malformations","volume":"19","author":"Flemming","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"9","key":"10.1016\/j.mayocp.2019.11.005_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.0b013e318248de9b","article-title":"The prospective hemorrhage risk of intracerebral cavernous malformations","volume":"78","author":"Flemming","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2019.11.005_bib14","author":"Morrison"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1474-4422(15)00303-8","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne","year":"2016","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib16","first-page":"1175","article-title":"Aggressive course of multiple de novo cavernous malformations","volume":"115","author":"Flemming","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0009-9260(02)00470-1","article-title":"De novo formation of a cavernous malformation of the brain in the presence of a developmental venous anomaly","volume":"58","author":"Cakirer","year":"2003","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3171\/2016.12.PEDS16600","article-title":"De novo formation of a large cavernoma associated with a congenital torcular dural arteriovenous fistula: case report","volume":"19","author":"Brinjikji","year":"2017","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1971400916666558","article-title":"De novo formation of cerebral cavernous malformation adjacent to existing developmental venous anomaly: an effect of change in venous pressure associated with management of a complex dural arterio-venous fistula","volume":"29","author":"Chakravarthy","year":"2016","journal-title":"Neuroradiol J"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib20","first-page":"156","article-title":"De novo development of a lesion with the appearance of a cavernous malformation adjacent to an existing developmental venous anomaly","volume":"26","author":"Campeau","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib21","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.3171\/foc.2006.21.1.5","article-title":"Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy","volume":"21","author":"Nimjee","year":"2006","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1227\/00006123-199604000-00006","article-title":"Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas","volume":"38","author":"Pozzati","year":"1996","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib23","doi-asserted-by":"crossref","first-page":"E739","DOI":"10.1227\/NEU.0000000000000002","article-title":"Magnetic resonance evolution of de novo formation of a cavernoma in a thrombosed developmental venous anomaly: a case report","volume":"73","author":"Su","year":"2013","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000121115","article-title":"De novo familial cavernous malformation presenting with hemorrhage 12.5 years after the initial hemorrhagic ictus: natural hisotory of an infantile form","volume":"25","author":"Tekkok","year":"1996","journal-title":"Pediatr Neurosurg"},{"issue":"9","key":"10.1016\/j.mayocp.2019.11.005_bib25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00381-017-3484-0","article-title":"Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age","volume":"33","author":"Brinjikji","year":"2017","journal-title":"Child Nerv Syst"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib26","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3171\/2011.3.FOCUS1165","article-title":"The natural history of intracranial cavernous malformations","volume":"30","author":"Gross","year":"2011","journal-title":"Neurosurg Focus"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib27","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1161\/STROKEAHA.112.668533","article-title":"Antithrombotic therapy and bleeding risk in a prospective cohort of patients with cerebral cavernous malformation","volume":"43","author":"Schneble","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/jnnp-2012-302599","article-title":"The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI","volume":"84","author":"Dammann","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib29","first-page":"570","article-title":"Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI","volume":"126","author":"Dammann","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","article-title":"Recent insights into cerebral cavernous malformations: the molecular genetics of CCM","volume":"277","author":"Riant","year":"2010","journal-title":"FEBS J"},{"issue":"16","key":"10.1016\/j.mayocp.2019.11.005_bib31","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","article-title":"Lesions from patients with sporadic cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis","volume":"23","author":"McDonald","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddn430","article-title":"Biallelic somatic and germline mutations in cerebral cavernous malformations: evidence for a two-hit mechanism of CCM pathogenesis","volume":"18","author":"Akers","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/neuros\/nyx091","article-title":"Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel","volume":"80","author":"Akers","year":"2017","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1161\/STROKEAHA.118.022314","article-title":"Familial cerebral cavernous malformations","volume":"50","author":"Zafar","year":"2019","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.mayocp.2019.11.005_bib35","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/hmg\/9.9.1351","article-title":"KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation","volume":"9","author":"Eerola","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000356839","article-title":"Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation","volume":"37","author":"Choquet","year":"2014","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib37","first-page":"211","article-title":"Genetics of cerebral cavernous malformations: current status and future prospects","volume":"59","author":"Choquet","year":"2015","journal-title":"J\u00a0Neurosurg Sci"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","article-title":"Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease","volume":"50","author":"Shenkar","year":"2019","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2014.97","article-title":"Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations","volume":"17","author":"Shenkar","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/svn-2018-000195","article-title":"CCM3 and cerebral cavernous malformation disease","volume":"4","author":"Wang","year":"2019","journal-title":"Stroke Vasc Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib41","first-page":"1214","article-title":"Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort","volume":"122","author":"Cutsforth-Gregory","year":"2015","journal-title":"J\u00a0Neurosurg"},{"issue":"12","key":"10.1016\/j.mayocp.2019.11.005_bib42","first-page":"3129","article-title":"Hemorrhage from cavernous malformations of the brain: definition and reporting standards","volume":"39","author":"Salman","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.mayocp.2019.11.005_bib43","author":"Flemming"},{"key":"10.1016\/j.mayocp.2019.11.005_bib44","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/j.wneu.2019.05.157","article-title":"Symptomatic cavernous malformation presenting with seizure without hemorrhage: analysis of factors Influencing clinical presentation","volume":"129","author":"Agosti","year":"2019","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2018-319553","article-title":"Clinical presentation, natural history and outcomes of intramedullary spinal cord cavernous malformations","volume":"90","author":"Goyal","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mayocp.2019.11.005_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.surneu.2007.06.039","article-title":"Outcome in 53 patients with spinal cord cavernomas","volume":"70","author":"Labauge","year":"2008","journal-title":"Surgical Neurology"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib47","first-page":"518","article-title":"Clinical, radiological, and pathological spectrum of angiographically occult intracranialvascular malformations: analysis of 21 cases and review of the literature","volume":"68","author":"Lobato","year":"1988","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1227\/00006123-198302000-00013","article-title":"Cavernomas of the brain","volume":"12","author":"Vaquero","year":"1983","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3174\/ajnr.A6076","article-title":"Baseline and evolutionary radiologic features in sporadic, hemorrhagic brain cavernous malformations","volume":"40","author":"Flemming","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib50","first-page":"1079","article-title":"Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis","volume":"126","author":"Gross","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"21","key":"10.1016\/j.mayocp.2019.11.005_bib51","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/WNL.0000000000002701","article-title":"Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies","volume":"86","author":"Taslimi","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib52","first-page":"56","article-title":"Natural history of intracranial cavernous malformations","volume":"83","author":"Aiba","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0090-3019(96)00425-9","article-title":"An analysis of the natural history of cavernous malformations","volume":"48","author":"Kim","year":"1997","journal-title":"Surg Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib54","first-page":"820","article-title":"The natural history of cerebral cavernous malformations","volume":"83","author":"Kondziolka","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002340050893","article-title":"The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients","volume":"42","author":"Labauge","year":"2000","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib56","first-page":"190","article-title":"Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage","volume":"87","author":"Porter","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib57","first-page":"15","article-title":"Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system","volume":"49","author":"Barker","year":"2001","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.mayocp.2019.11.005_bib58","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/BF01411299","article-title":"Early radiologically proven rebleeding from intracranial cavernous angiomas: report of 6 cases and review of the literature","volume":"139","author":"Duffau","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1042-3680(18)30175-X","article-title":"The natural history of cavernous malformations","volume":"10","author":"Moriarity","year":"1999","journal-title":"Neurosurg Clin N Am"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib60","first-page":"709","article-title":"Natural history of the cavernous angioma","volume":"75","author":"Robinson","year":"1991","journal-title":"J\u00a0Neurosurg"},{"issue":"18","key":"10.1016\/j.mayocp.2019.11.005_bib61","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182190f37","article-title":"Seizure risk from cavernous or arteriovenous malformations: prospective population-based study","volume":"76","author":"Josephson","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2019.11.005_bib62","author":"Rinkel"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib63","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2010.6.FOCUS10133","article-title":"Brainstem cavernous malformations: anatomical, clinical, and surgical considerations","volume":"29","author":"Giliberto","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.mayocp.2019.11.005_bib64","author":"Nagy"},{"key":"10.1016\/j.mayocp.2019.11.005_bib65","author":"Nagy"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/WCO.0000000000000662","article-title":"Laser interstitial thermal therapy in drug-resistant epilepsy","volume":"32","author":"Shimamoto","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2019.11.005_bib67","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/epi.12402","article-title":"Cavernoma-related epilepsy: review and recommendations for mangement: report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies","volume":"54","author":"Rosenow","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jnnp.66.5.561","article-title":"Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series","volume":"66","author":"Moran","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0303-8467(97)00023-1","article-title":"Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients","volume":"99","author":"Cappabianca","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2008.05.010","article-title":"Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients","volume":"18","author":"Yeon","year":"2009","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2007.01.001","article-title":"Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy","volume":"16","author":"Hammen","year":"2007","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib72","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1167.2006.00941.x","article-title":"Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients","volume":"48","author":"Baumann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.mayocp.2019.11.005_bib73","author":"Bervini"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib74","first-page":"43","article-title":"Use of antithrombotic agents in patients with intracerebral cavernous malformations","volume":"118","author":"Flemming","year":"2013","journal-title":"J\u00a0Neurosurg"},{"issue":"10","key":"10.1016\/j.mayocp.2019.11.005_bib75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1474-4422(19)30231-5","article-title":"Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis","volume":"18","author":"Zuurbier","year":"2019","journal-title":"Lancet Neurol"},{"issue":"pt B","key":"10.1016\/j.mayocp.2019.11.005_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","article-title":"Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin","volume":"81","author":"Retta","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib77","first-page":"50","article-title":"Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy","volume":"118","author":"Kalani","year":"2013","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib78","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1227\/NEU.0b013e31825fd0dc","article-title":"Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management","volume":"71","author":"Witiw","year":"2012","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10143-018-01074-0","article-title":"Could propranolol be beneficial in adult cerebral cavernous malformations?","volume":"42","author":"Apra","year":"2019","journal-title":"Neurosurg Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0009922813492885","article-title":"Propranolol for cerebral cavernous angiomatosis: a magic bullet","volume":"53","author":"Berti","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.mayocp.2019.11.005_bib81","author":"Goldberg"},{"key":"10.1016\/j.mayocp.2019.11.005_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2016.04.053","article-title":"Propranolol stops progressive multiple cerebral cavernoma in an adult patient","volume":"367","author":"Reinhard","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.mayocp.2019.11.005_bib83","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.wneu.2015.11.003","article-title":"Propranolol treatment of cavernous malformations with symptomatic hemorrhage","volume":"88","author":"Zabramski","year":"2016","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib85","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.molmed.2013.02.004","article-title":"Cerebral cavernous malformations: from CCM genes to endothelial homeostasis","volume":"19","author":"Fischer","year":"2013","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000369200","article-title":"Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity","volume":"38","author":"Choquet","year":"2014","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.005_bib87","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.025","article-title":"Infratentorial developmental venous abnormalities and inflammation increase odds of sporadic cavernous malformation","volume":"28","author":"Kumar","year":"2019","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"7654","key":"10.1016\/j.mayocp.2019.11.005_bib88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature22075","article-title":"Endothelial TLR4 and the microbiome drive cerebral cavernous malformations","volume":"545","author":"Tang","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib89","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamaneurol.2018.3634","article-title":"Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review","volume":"76","author":"Chohan","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","article-title":"Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation","volume":"131","author":"Gibson","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2019.11.005_bib91","doi-asserted-by":"crossref","first-page":"15389","DOI":"10.1021\/acsomega.8b01653","article-title":"Multifunctional platinum@BSA-rapamycin nanocarriers for the combinatorial therapy of cerebral cavernous malformation","volume":"3","author":"De Luca","year":"2018","journal-title":"ACS Omega"},{"issue":"28","key":"10.1016\/j.mayocp.2019.11.005_bib92","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.1000132107","article-title":"Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling","volume":"107","author":"Wustehube","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.mayocp.2019.11.005_bib93","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1073\/pnas.1501352112","article-title":"Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice","volume":"112","author":"Bravi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib94","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/STROKEAHA.111.625467","article-title":"Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease","volume":"43","author":"McDonald","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib95","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/STROKEAHA.116.015013","article-title":"RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations","volume":"48","author":"Shenkar","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib96","doi-asserted-by":"crossref","first-page":"N25","DOI":"10.1093\/neuros\/nyx100","article-title":"Fasudil slows development of\u00a0cavernous malformations","volume":"80","author":"Weiner","year":"2017","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.005_bib97","first-page":"102","article-title":"Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations","volume":"127","author":"Girard","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"10","key":"10.1016\/j.mayocp.2019.11.005_bib98","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/jcbfm.2015.98","article-title":"Vascular permeability in cerebral cavernous malformations","volume":"35","author":"Mikati","year":"2015","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.005_bib99","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/STROKEAHA.113.003548","article-title":"Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations","volume":"45","author":"Mikati","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.005_bib100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12975-013-0285-y","article-title":"Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations","volume":"4","author":"Hart","year":"2013","journal-title":"Transl Stroke Res"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.005_bib101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/bmm.15.118","article-title":"Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease","volume":"10","author":"Girard","year":"2016","journal-title":"Biomark Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.11.005_bib102","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/CIRCRESAHA.118.312680","article-title":"Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth","volume":"122","author":"Girard","year":"2018","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.005_bib103","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/neuros\/nyy108","article-title":"Trial Readiness in Cavernous Angiomas with Symptomatic Hemorrhage (CASH)","volume":"84","author":"Polster","year":"2019","journal-title":"Neurosurgery"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619309966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619309966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:34:24Z","timestamp":1758418464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619309966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0025619619309966"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Cavernous Malformation: What a Practicing Clinician Should Know","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}